Advanced Solid Tumor

Showing NaN - NaN of 39

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumor Trial in United States (CLN-617, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • Los Angeles, California
  • +5 more
Sep 12, 2023

Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),

Recruiting
  • Solid Tumor, Adult
  • +19 more
  • Irving, Texas
  • +2 more
May 24, 2023

Advanced Solid Tumor Trial in San Antonio, Anderlecht, Madrid (PM54)

Recruiting
  • Advanced Solid Tumor
  • San Antonio, Texas
  • +2 more
Apr 21, 2023

Advanced Solid Tumor Trial in San Antonio (LB101)

Recruiting
  • Advanced Solid Tumor
  • San Antonio, Texas
    NEXT Oncology
Apr 6, 2023

Advanced Solid Tumor Trial in Worldwide (Erdafitinib)

Recruiting
  • Advanced Solid Tumor
  • Tucson, Arizona
  • +199 more
Jan 27, 2023

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma Trial in San Antonio (SRF114)

Recruiting
  • Advanced Solid Tumor
  • Head and Neck Squamous Cell Carcinoma
  • San Antonio, Texas
    START- San Antonio
Jan 2, 2023

Tumor, Solid, Tumor, Advanced Solid Tumor Trial in San Antonio, West Valley City (nab-sirolimus)

Recruiting
  • Tumor, Solid
  • +2 more
  • San Antonio, Texas
  • +1 more
Dec 14, 2022

Advanced Cancer, Advanced Solid Tumor, Cancer Trial in Scottsdale, San Antonio (STC-15)

Recruiting
  • Advanced Cancer
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Dec 18, 2022

Advanced Solid Tumor Trial in United States (GS-1811, Zimberelimab)

Recruiting
  • Advanced Solid Tumor
  • La Jolla, California
  • +8 more
Dec 8, 2022

Advanced Solid Tumor Trial in Australia, United States (CLN-619, Pembrolizumab)

Recruiting
  • Advanced Solid Tumor
  • Duarte, California
  • +15 more
Nov 30, 2022

Advanced Solid Tumor Trial in Canada, United States (SRF617, Gemcitabine, Albumin-Bound Paclitaxel)

Active, not recruiting
  • Advanced Solid Tumor
  • Duarte, California
  • +9 more
Nov 28, 2022

Advanced Solid Tumor, Lymphoma Trial in United States (ALPN-202, Pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumor
  • Lymphoma
  • Atlanta, Georgia
  • +4 more
Nov 8, 2022

Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • PY159 Single agent dose level 1
  • +17 more
  • San Francisco, California
  • +11 more
Nov 3, 2022

Advanced Solid Tumor Trial in United Kingdom, United States (CDK-002)

Active, not recruiting
  • Advanced Solid Tumor
  • CDK-002
  • Scottsdale, Arizona
  • +7 more
Sep 27, 2022

Advanced Solid Tumor, NSCLC Trial (HB0036)

Recruiting
  • Advanced Solid Tumor
  • NSCLC
  • San Antonio, Texas
    Next Oncology
Sep 14, 2022

Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer Trial in United States (SY-5609, Fulvestrant, Gemcitabine)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Gilbert, Arizona
  • +16 more
Sep 13, 2022

Advanced Solid Tumor Trial in Canton, Austin, San Antonio (Tipifarnib)

Recruiting
  • Advanced Solid Tumor
  • Canton, Ohio
  • +2 more
Aug 19, 2022

NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma Trial in Nashville, San Antonio, Fairfax (RMC-6291)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • +3 more
  • San Antonio, Texas
  • +1 more
Aug 16, 2022

Advanced Solid Tumor, Advanced Malignant Tumor, Metastatic Cancer Trial in United States (PC14586)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
  • +10 more
Aug 12, 2022

Metastatic Solid Tumor, Advanced Solid Tumor Trial in United States (WTX-124, Pembrolizumab)

Recruiting
  • Metastatic Solid Tumor
  • Advanced Solid Tumor
  • Scottsdale, Arizona
  • +4 more
Aug 3, 2022

Advanced Solid Tumor Trial in Los Angeles, Dallas, San Antonio (UCT-03-008)

Recruiting
  • Advanced Solid Tumor
  • Los Angeles, California
  • +2 more
Jul 25, 2022